Target audience: Physicians, Physician Associates, Nurse and Nurse Practitioners, Pharmacists and the Interprofessional team.Credit designations available: AMA PRA Category 1 Credit™, AAPA Category 1 CME Credit, Nursing Contact Hour(s)
Educational objectives: At the conclusion of this activity participants should be able to:
Describe the overlap between palliative care and substance use disorder populations, including shared prevalence trends, stigma, symptom burden, and pharmacologic considerations (e.g., opioids, benzodiazepines).
Identify barriers and workforce gaps that affect the quality of end-of-life care for patients with SUD and recognize how clinician discomfort can lead to avoidant or overly restrictive care.
Apply risk stratification and severity assessment tools — such as the Karnofsky Performance Status, Palliative Performance Scale, ECOG, and DSM-5 SUD severity criteria — to guide multidisciplinary treatment planning.
Integrate palliative care philosophies into SUD treatment — centering patient autonomy and dignity — across the full disease trajectory, from screening and diagnosis through remission, relapse, and bereavement.
In support of improving patient care, this activity has been planned and implemented by PCSS-MOUD and American Academy of Addiction Psychiatry. American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
PhysiciansAmerican Academy of Addiction Psychiatry designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurses and Nurse PractitionersAmerican Academy of Addiction Psychiatry is an approved provider of nursing continuing education through AAAP’s Joint Accreditation provider #4008192. This activity is approved for up to 1.0 CNE credits.PAs
American Academy of Addiction Psychiatry has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
In accordance with the disclosure policy of the American Academy of Addiction Psychiatry, as well as standards set forth by JAC policies and guidelines and the ACCME, the JAC expects accredited providers to present learners with unbiased, independent, and objective information in all activities. Accredited providers must be in compliance with the Standards for Integrity and Independence in Accredited Continuing Education. Therefore, Presenter(s), Planner(s), Reviewer(s), and all others involved in the planning or content development of this activity were required to disclose all financial relationships within the past 24 months.All disclosures have been reviewed and there are no relevant financial relationships with ineligible companies to disclose.All speakers have been advised that any recommendations involving clinical medicine must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in the presentation must conform to the generally accepted standards of experimental design, data collection, and analysis. Faculty have also been advised that they must not actively promote or sell products or services that serve their professional or financial interests during accredited education.